почта: bd@sidmexinovia.com
Телефон: +918866862020
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Главная >
Lenvanamo 10mg Capsule
Lenvanamo 10mg Capsule
Manufacturer/Marketed By : SHIVNAAM TRADELINK LLP
$122.68 $49.07
Lenvanamo 10mg Tablet is composed of the active ingredient Lenvatinib. It is a tyrosine kinase inhibitor indicated for progressive or advanced thyroid cancer when radioactive iodine therapy is not beneficial....
Сворачиваемый текст идеально подходит для длинных текстов, таких как абзацы и описания. Это отличный способ предоставить людям больше информации, сохраняя при этом лаконичность макета. Вы можете связать текст с чем угодно, включая внешний веб-сайт или другую страницу. Вы можете настроить текстовое поле так, чтобы оно разворачивалось и сворачивалось при щелчке пользователя, позволяя ему прочитать больше или меньше информации.
LENVATINIB
Active Pharmaceutical Ingredient
Lenvanamo 10mg Capsule
122,68 $
49,07 $
Lenvanamo 10mg Tablet is composed of the active ingredient Lenvatinib. It is a tyrosine kinase inhibitor indicated for progressive or advanced thyroid cancer when radioactive iodine therapy is not beneficial. It is also used to treat previously untreated liver cancer patients who are not eligible for surgical treatment. Anaplastic Thyroid Carcinoma (Advanced thyroid cancer) usually occurs in patients above 60 years of age. It is characterized by an enlarged and hard thyroid gland and hoarseness in the voice due to paralysis of the nerve in the voice box. Hepatocellular carcinoma (liver cancer) develops due to preexisting liver conditions such as cirrhosis or chronic hepatitis B infection. Patients who have had an allergic reaction to Lenvanamo 10mg Tablet or any of its components should not take this medication. Patients should inform their dentist or oral surgeon that they are taking Lenvanamo 10mg Tablet, as it can impair wound healing and increase the risk of bleeding.
Active Pharmaceutical Ingredient
Применение
• Certain types of advanced thyroid cancer
• Advanced Liver cancer
• Certain types of kidney cancer
• Endometrial cancer
Преимущества
Lenvanamo 10mg Tablet blocks the enzyme receptor tyrosine kinases (RTKs). RTKs develop new blood vessels that supply oxygen and nutrients to the cells and help them grow. This medicine inhibits the receptors that facilitate the growth of blood vessels in tumour cells. RTKs are present in high concentrations in cancer cells, and administration of this medicine slows down the rate of cancer cells’ growth and multiplication.
Побочные эффекты
Like all medications, Lenvanamo 10mg Tablet can cause side effects, although not everyone who takes it will experience them.
Наиболее распространенные побочные эффекты
• Fatigue
• Loss of appetite
• Weight loss
• Nausea and vomiting
• Diarrhea
• Stomach pain or discomfort
• Hypertension (high blood pressure)
• Headache
• Joint pain or muscle pain
• Changes in taste
Распространенные побочные эффекты
• Liver toxicity or liver failure
• Heart problems, such as heart attack
• Hemorrhage (bleeding)
• Blood clots
• Poor wound healing
• Kidney failure
• Hypothyroidism
• Skin reactions (rash or blisters)
Как использовать
Lenvanamo 10mg Tablet is an oral medication that is usually taken once a day, at approximately the same time each day, with or without food. It should be taken as prescribed by a doctor or other healthcare provider. These capsules should be swallowed whole with a glass of water. They should not be crushed, chewed, or opened, as this can affect the way the medication is absorbed and decrease its effectiveness. You should not take a double dose to make up the second dose.
Safety Advice
• Breast Feeding: Breastfeeding is not recommended while taking Lenvanamo 10mg Tablet, as it can potentially harm the nursing infant.
• Alcohol: It is recommended to avoid consuming alcohol while taking Lenvanamo 10mg Tablet, as alcohol can increase the risk of certain side effects associated with the medication, such as stomach ulcers or gastrointestinal bleeding.
• Liver: Lenvanamo 10mg Tablet is primarily metabolized in the liver, so inform your healthcare provider if you have any liver problems or diseases. This medication may also increase liver enzymes, which can be a sign of liver damage or inflammation. Patients taking this medication require regular blood tests to monitor liver function.
• Lungs: Lenvanamo 10mg Tablet can cause side effects that affect the lungs, such as cough, shortness of breath, and difficulty breathing. If a person experiences any of these symptoms while taking it, they should notify their healthcare provider right away.
• Driving: Patients receiving Lenvanamo 10mg Tablet should be advised to avoid driving or operating machinery if they experience side effects such as fatigue, dizziness, or blurred vision, impairing a patient's ability to drive or operate machinery safely.
• Pregnancy: Lenvanamo 10mg Tablet is unsafe during pregnancy as it can cause fetal harm. It is s recommended to avoid this medication during pregnancy.
Отказ от ответственности
Компания Sidmex Inovia стремится предоставлять точную и достоверную информацию; однако весь контент на этом веб-сайте, включая описания и состав продуктов, предназначен только для информационных целей и не должен рассматриваться как замена профессиональной медицинской консультации, диагностики или лечения.
Пользователям рекомендуется проконсультироваться с квалифицированным медицинским специалистом, прежде чем принимать какие-либо медицинские решения. Предоставленная информация не должна использоваться для самодиагностики или самолечения.
Все перечисленные продукты предназначены исключительно для B2B и оптовых запросов. Sidmex Inovia не пропагандирует прямое использование потребителями и стремится поддерживать, а не заменять отношения между медицинским работником и пациентом.
Названия продуктов, товарные знаки и бренды принадлежат их соответствующим владельцам, и их использование не подразумевает какой-либо связи или одобрения. Sidmex Inovia не несет ответственности за любые последствия, возникающие в результате использования информации, предоставленной на этом веб-сайте.